Drug Shortage Report for VFEND

Last updated on 2019-07-03 History
Report ID 72891
Drug Identification Number 02279991
Brand name VFEND
Common or Proper name VFEND
Company Name PFIZER CANADA ULC
Active Ingredient(s) VORICONAZOLE
Strength(s) 3G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size BTL 70ml
ATC code J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-01-25
Estimated end date
Actual end date 2019-05-13
Shortage status Resolved
Updated date 2019-07-03
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-07-03 French Compare
v12 2019-07-03 English Compare
v11 2019-07-03 English Compare
v10 2019-03-29 French Compare
v9 2019-03-29 English Compare
v8 2019-03-21 French Compare
v7 2019-03-21 English Compare
v6 2019-01-26 English Compare
v5 2019-01-25 French Compare
v4 2019-01-25 English Compare
v3 2019-01-18 French Compare
v2 2019-01-18 English Compare
v1 2019-01-18 English Compare